Article Details

Cerevel Therapeutics (NASDAQ:CERE) Price Target Increased to $39.00 by Analysts at ...

Retrieved on: 2021-09-07 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Cerevel Therapeutics (NASDAQ:CERE) Price Target Increased to $39.00 by Analysts at .... View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 3,524,716 shares of the biotechnology company's stock valued at $90,304,000 after buying an additional 296,575 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up